Drugs and Children: Methods for Therapeutic Monitoring

References

• Marks V., Lindup W. E., Baylis E. M. Measurement of Therapeutic Agents in Blood. Advances in Clinical Chemistry, O. Bodansky, A. L. Latner. Academic, New York 1974; Vol. 16: 47–109
   Google Scholar
• Vesell E. S., Passananti G. T. Utility of clinical chemical determination of drug concentrations in biological fluids: A review. Clin. Chem. 1971; 17: 851
   PubMed Web of Science ®Google Scholar
• O'Brien D., Ibbott F. A., Rodgerson D. O. Laboratory Manual of Pediatric Microbiochemical Techniques, 4th ed. Harper and Row, New York 1968
   Google Scholar
• Tompsett S. Interferences from the presence of other substances in detecting and determining barbiturates in biological material. J. Clin. Pathol. 1969; 22: 291
   PubMed Web of Science ®Google Scholar
• Cooper R., Greaves M., Owen G. Diphenylhydantoin interferences with spectrophotometric barbiturate estimation. Clin. Chem. 1973; 19: 422
   Google Scholar
• Gupta R., Keane P. Diphenylhydantoin interferences with spectrophotometric barbiturate estimations. Clin. Chem. 1973; 19: 1318
   PubMed Web of Science ®Google Scholar
• Toseland P. A., Albani M., Ganchel F. D. Organic nitrogenselective detector used in gas-chromatographic determination of some anticonvulsants and barbiturate drugs in plasma and tissues. Clin. Chem. 1975; 21: 144
   PubMedGoogle Scholar
• Richens A. Results of a Phenytoin Quality Control Scheme. Clinical Pharmacology of Antiepileptic Drugs, H. Schneider. Springer-Verlag, Berlin 1975; 293–303
   Google Scholar
• Pippenger C. E., Perry J. K., White B. G., Daly D. D., Buddington R. Interlaboratory variability in determination of antiepileptic drugs. Arch. Neurol. 1976; 33: 351
   PubMed Web of Science ®Google Scholar
• Reeves D. S. Accuracy of gentamicin assays. Postgrad. Med. J. 1974; 50: 20, Suppl. 7
   PubMed Web of Science ®Google Scholar
• Kupferberg H. J., Perry J. K. The Development of Matrix Reference Standard for Anticonvulsant Analysis. Clinical Pharmacology of Anti-epileptic Drugs. Springer-Verlag, Berlin, in press
   Google Scholar
• Glazko A. J., Dill W. A., Rebstock M. C. Biochemical studies on chloramphenicol (chloromycetin). III. Isolation and identification of metabolic products in urine. J. Biol. Chem. 1950; 183: 679
   Web of Science ®Google Scholar
• Levine J., Fischbach H. The chemical determination of chloramphenicol in biological materials. Antibiot. Chemotherap. (Basel) 1951; 1: 59
   Google Scholar
• Glazko A. J. Colorimetric Procedure for the Determination of Chloramphenicol and Related Nitro Compounds. Parke Davis Research Laboratories, Ann Arbor, Michigan
   Google Scholar
• Hughes D. W. O'G., Diamond L. K. Chloramphenicol in blood: Simple chemical estimations in patients receiving multiple antibiotics. Science 1964; 144: 296
   PubMed Web of Science ®Google Scholar
• Kakemi K., Arita T., Ohashi S. Absorption and excretion of drugs. IV. Determination of chloramphenicol in blood. J. Pharm. Soc. Japan 1962; 82: 342
   Google Scholar
• Kakemi K., Arita T., Ohashi S. Absorption and excretion of drugs. V. Determination of chloramphenicol in urine and its metabolic rate. J. Pharm. Soc. Japan 1962; 82: 345
   PubMedGoogle Scholar
• Andersen J. B., Rosdahl N., Vejlsgaard R. Aspects of pharmacology of gentamicin in newborn infants. Acta Pediat. Scand. 1972; 61: 343
   PubMed Web of Science ®Google Scholar
• McCracken G. H. Clinical pharmacology of gentamicin in infants 2–24 months of age. Am. J. Diseases Child. 1972; 124: 884
   PubMedGoogle Scholar
• McCracken G. H., Jones L. G. Gentamicin in the neonatal period. Am. J. Diseases Child. 1970; 120: 524
   PubMedGoogle Scholar
• Winters R. E., Litwack K. D., Hewitt W. L. Relation between dose and levels of gentamicin in blood. J. Infect. Diseases 1971; 124: 590, (Suppl.)
   Web of Science ®Google Scholar
• Smith D. H., Van Otto B., Smith A. L. A rapid chemical assay for gentamicin. New Engl. J. Med. 1972; 286: 583
   PubMed Web of Science ®Google Scholar
• Haas M. J., Davies J. Enzymatic acetylation as a means of determining serum aminoglycoside concentrations. Antimicrob. Agents Chemotherap. 1973; 4: 497
   PubMed Web of Science ®Google Scholar
• Broughall J. M., Reeves D. S. The acetyl transferase enzyme method for the assay of serum gentamicin concentrations and a comparison with other methods. J. Clin. Pathol. 1975; 28: 140
   PubMed Web of Science ®Google Scholar
• Weinstein L., Samet C. A. Sulfonamide blood levels and serum antibacterial activity. Arch. Intl. Med. 1962; 110: 794
   Web of Science ®Google Scholar
• Weinstein L. The Sulfonamides. The Pharmacological Basis of Therapeutics, L. S. Goodman, A. Gilman. MacMillan, New York 1970; 1184
   Google Scholar
• Bratton A. D., Marshall E. K. A new coupling reagent for sulfanilamide determination. J. Biol. Chem. 1939; 128: 537
   Google Scholar
• Annino J. S. Sulfonamides. Standard Methods of Clinical Chemistry, D. Seligson. Academic, New York 1961; Vol. 3: 200
   Google Scholar
• O'Brien D., Ibbott F. A., Rodgerson D. O. Determination of Sulfonamides in Biological Fluids. Laboratory Manual of Pediatric Micro-Biochemical Techniques, 4th ed. Harper and Row, New York 1968; 306
   Google Scholar
• Turner-Warwich M. Study of theophylline plasma levels after oral administration of new theophylline compounds. Brit. Med. J. 1957; ii: 67
   Google Scholar
• Jenne J. W., Wyze E., Rood F. S., MacDonald F. M. The pharmacokinetics of theophylline: application to adjustment of the clinical dose of aminophylline. Clin. Pharmacol. Therap. 1972; 13: 349
   PubMed Web of Science ®Google Scholar
• Mitenko P. A., Ogilvie R. I. Rational intravenous doses of theophylline. New Engl. J. Med. 1973; 289: 600
   PubMed Web of Science ®Google Scholar
• Weinberger M. M., Bronsky E. A. Evaluation of bronchodilator therapy in asthmatic children. J. Pediat. 1974; 84: 421
   PubMed Web of Science ®Google Scholar
• Zwiech C. W., Sutton F. D., Neff T. A., Cohn W. M., Matthay R. A., Weinberger M. M. Theophylline-induced seizures in adults: Correlation with serum concentrations. Ann. Int. Med. 1975; 82: 784
   PubMed Web of Science ®Google Scholar
• Piapky K. M., Ogilvie R. I. Dosage of theophylline in asthmatic children. New Engl. J. Med. 1975; 292: 1218
   PubMedGoogle Scholar
• Weinberger M., Chidsey C. Rapid analysis of theophylline in serum by use of high-pressure cation-exchange chromatography. Clin. Chem. 1975; 21: 834
   PubMed Web of Science ®Google Scholar
• Koysooko R., Ellis E. F., Levy G. Relationship between theophylline concentration in plasma and saliva of man. Clin. Pharmacol. Therap. 1973; 15: 454
   Web of Science ®Google Scholar
• Levy G., Ellis E. F., Koysook R. Indirect plasma theophylline monitoring in asthmatic children by determination of theophylline concentrations in saliva. Pediatrics 1974; 53: 873
   PubMed Web of Science ®Google Scholar
• Shack J. A., Waxler S. H. An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues. J. Pharmacol. Exptl. Therap. 1949; 97: 283
   PubMed Web of Science ®Google Scholar
• Gupta R. D., Lundberg G. D. Quantitative determination of theophylline in blood by differential spectrophotometry. Anal. Chem. 1973; 45: 2403
   Web of Science ®Google Scholar
• Ellis E., Cordell J., Clemente D., Hammond K. Determination of theophylline in biological fluids, submitted for publication
   Google Scholar
• Shah V. P., Riegelman S. Gas-liquid chromatographic determination of theophylline in biological fluids. J. Pharm. Sci. 1974; 63: 1283
   PubMed Web of Science ®Google Scholar
• Johnson G. F., Dechtiaruk W. A., Solomon H. M. Gaschromatographic determination of theophylline in human serum and saliva. Clin. Chem. 1975; 21: 144
   PubMed Web of Science ®Google Scholar
• Dechtiaruk W., Johnson G. F., Solomon H. M. Faster gaschromatographic procedure for theophylline. Clin. Chem. 1975; 21: 1038, (Letter)
   PubMed Web of Science ®Google Scholar
• Thompson R. D., Nagasawa H. T., Jenne J. W. Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography. J. Lab. Clin. Med. 1974; 84: 584
   PubMed Web of Science ®Google Scholar
• Faerø O., Dastrup K. W., Melchior J. C., Thom I. Phenobarbital as prophylaxis for febrile convulsions: A preliminary report. Epilepsia 1971; 12: 109
   PubMed Web of Science ®Google Scholar
• Melchior J. C., Buchthal F., Lennox-Buchthal M. The ineffectiveness of diphenylhydantoin in preventing febrile convulsions in the age of greatest risk under three years. Epilepsia 1971; 12: 55
   PubMed Web of Science ®Google Scholar
• Faerø O., Kastrup K. W., Lykkegaard Nielsen E., Melchior J. C., Thom I. Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia 1972; 13: 279
   PubMed Web of Science ®Google Scholar
• Buchthal F., Svensmark O., Simonsen H. Relation of EEG and seizures to phenobarbital in serum. Arch. Neurol. (Chicago) 1968; 19: 567
   PubMed Web of Science ®Google Scholar
• Lennox-Buchthal M. A. Febrile convulsions: a reappraisal. Electroenceph. Clin. Neurophysiol. 1973, Suppl. 32
   PubMedGoogle Scholar
• McMorris S., McWilliams P. K. A. Status epilepticus in infants and young children treated with parenteral diazepam. Arch. Diseases Child. 1969; 44: 604
   PubMed Web of Science ®Google Scholar
• Svensmark O., Buchthal F. Accumulation of phenobarbital in man. Epilepsia 1963; 4: 199
   PubMed Web of Science ®Google Scholar
• Goldbaum L. R. Analytical determination of barbiturates. Anal. Chem. 1952; 24: 1604
   Web of Science ®Google Scholar
• Broughton P. M. G. Ultraviolet method for the determination and identification of barbiturates in biological material. Biochem. J. 1956; 63: 207
   PubMed Web of Science ®Google Scholar
• Baylis E. M., Fry D. E., Marks V. Micro-determination of serum phenobarbitone and diphenylhydantoin by gas-liquid chromatography. Clin. Chim. Acta 1970; 30: 93
   PubMed Web of Science ®Google Scholar
• Kållberg N., Agurell S., Jalling B., Boreus L. O. Rapid gas chromatographic determination of phenobarbital in small plasma samples. Europ. J. Clin. Pharmacol. 1971; 3: 185
   Web of Science ®Google Scholar
• Kupferberg H. J. Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography. Clin. Chim. Acta 1970; 29: 283
   Web of Science ®Google Scholar
• Meijer J. W. A. Simultaneous quantitative determination of antiepileptic drugs including carbamazepine in body fluids. Epilepsia 1971; 12: 341
   PubMed Web of Science ®Google Scholar
• Brochmann-Hannessen E., Olawuji-Oke T. Gas chromatography of barbiturates, phenolic ankaloids, and xanthine bases: Glask heater methylation by means of trimethylanilinium hydroxide. J. Pharm. Sci. 1969; 58: 370
   PubMed Web of Science ®Google Scholar
• Anders M. W. Rapid Micro-method for gas-chromatographic determination of blood barbiturates. Anal. Chem. 1966; 38: 1945
   PubMed Web of Science ®Google Scholar
• Lennox W. G. The petit mal epilepsies; their treatment with Tridione. JAMA 1945; 129: 1069
   PubMed Web of Science ®Google Scholar
• Svensmark O., Buchthal F. Diphenylhydantoin and phenobarbital. Serum levels in children. Am. J. Diseases Child. 1964; 108: 82
   PubMedGoogle Scholar
• Kutt H., Winters W., Kokenge R., McDowell F. Diphenylhydantoin metabolism, blood levels and toxicity. Arch. Neurol. 1964; 11: 642
   PubMed Web of Science ®Google Scholar
• Hansen J. M., Kristensen M., Skovsted L. Sulthiame (Ospolot) as inhibitor of diphenylhydantoin metabolism. Epilepsia 1968; 9: 17
   PubMed Web of Science ®Google Scholar
• Olesen O. V. Determination of sulthiame (Ospolot) in serum and urine by thin-layer chromatography: serum levels and urinary output in patients under long-term treatment. Acta Pharmacol. Toxicol. 1968; 26: 22
   PubMedGoogle Scholar
• Huisman J. W., Van Heycep Tentham H. W., Van Zyl C. H. W. Influence of ethylphenacemide on serum levels of other anti-epileptic drugs. Epilepsia 1970; 11: 207
   PubMed Web of Science ®Google Scholar
• Christensen L. K., Skovsted L. Inhibition of drug metabolism by chloramphenicol. Lancet 1969; ii: 1397
   Google Scholar
• Hansen J. M., Kristensen M., Skovsted L., Christensen L. K. Dicoumarol-induced diphenylhydantoin intoxication. Lancet 1966; ii: 265
   Google Scholar
• Kutt H., Winters W., McDowell F. Depression of p-hydroxylation of diphenylhydantoin by antituberculous chemotherapy. Neurology 1966; 16: 594
   PubMed Web of Science ®Google Scholar
• Solomon H. M., Schrogie J. J. The effect of phenyramidol on the metabolism of diphenylhydantoin. Clin. Pharmacol. Therap. 1967; 8: 554
   PubMed Web of Science ®Google Scholar
• Reidenberg M. M., Odar-Cederlof I., Von Bahr C., Borga O., Sjoquist F. Protein-binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl. J. Med. 1971; 285: 264
   PubMed Web of Science ®Google Scholar
• Buchthal F., Svensmark O., Schiller P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin. A. M. A. Arch. Neurol. 1960; 2: 624
   PubMed Web of Science ®Google Scholar
• Kutt H., McDowell F. Management of epilepsy with diphenylhydantoin sodium. JAMA 1968; 203: 969
   PubMed Web of Science ®Google Scholar
• Logan W. J., Freeman J. M. Psuedodegenerative disease due to diphenylhydantoin intoxication. Arch. Neurol. 1969; 21: 631
   PubMed Web of Science ®Google Scholar
• Patel H., Chrichton J. V. The neurologic hazards of diphenylhydantoin in childhood. J. Pediat. 1968; 73: 676
   PubMed Web of Science ®Google Scholar
• Roseman E. Dilantin toxicity: A clinical and electroencephalographic study. Neurology (Minneapolis) 1961; 11: 912
   PubMed Web of Science ®Google Scholar
• Kutt H., Winters W., Scherman R., McDowell F. Diphenylhydantoin and phenobarbital toxicity. Arch. Neurol. 1964; 11: 649
   PubMed Web of Science ®Google Scholar
• Buchanan R. A., Kinkel A. W., Goulet J. R., Smith T. C. The metabolism of diphenylhydantoin (Dilantin) following oncedaily administration. Neurology 1972; 22: 126
   PubMed Web of Science ®Google Scholar
• Dill W. A., Bankema J., Chang T., Glazko A. J. Colorimetric assay of 5, 5-diphenylhydantoin (Dilantin) and 5- (-p-hydroxyphenol)- 5-phenylhydantoin. Proc. Soc. Exptl. Biol. Med. 1974; 137: 674
   Google Scholar
• Place G. L., Hine C. H. A method for the simultaneous determination of phenobarbital and diphenylhydantoin in blood. J. Lab. Clin. Med. 1956; 47: 649
   PubMedGoogle Scholar
• Svensmark O., Kristensen P. Determination of diphenylhydantoin and phenobarbital in small amounts of serum. J. Lab. Clin. Med. 1963; 61: 501
   PubMed Web of Science ®Google Scholar
• Simon G. E., Jatlow P. I., Seligson H. T., Seligson D. Measurement of 5, 5-diphenylhydantoin in blood using thinlayer chromatography. Am. J. Clin. Pathol. 1971; 55: 145
   PubMed Web of Science ®Google Scholar
• Sandberg D. H., Resnick G. L., Bacallao C. Z. Measurement of serum diphenylhydantoin by gas-liquid chromatography. Anal. Chem. 1968; 40: 736
   PubMed Web of Science ®Google Scholar
• Pippenger C. E., Gillen H. W. Gas chromatographic analysis for anticonvulsant drugs in biological fluids. Clin. Chem. 1969; 15: 582
   PubMed Web of Science ®Google Scholar
• Kupferberg H. J. Quantitative estimation of diphenylhydantoin, primidone, and phenobarbital in plasma by gas-liquid chromatography. Clin. Chim. Acta 1970; 29: 283
   Web of Science ®Google Scholar
• Chang T., Glazko A. J. Quantitative assay of 5, 5-phenylhydantoin by gas-liquid chromatography. J. Lab. Clin. Med. 1970; 75: 145
   PubMedGoogle Scholar
• Sampson D., Harasymit I., Hensley W. J. Gas-chromatographic assay of underivatized 5, 5-diphenylhydantoin (Dilantin) in plasma extracts. Clin. Chem. 1971; 17: 382
   PubMed Web of Science ®Google Scholar
• Gardner-Thorpe C., Parsonage M. J., Smethurst P. F., Toothill C. A comprehensive gas chromatographic scheme for the estimation of antiepileptic drugs. Clin. Chim. Acta 1972; 36: 223
   PubMed Web of Science ®Google Scholar
• Solow E. B., Green J. B. The simultaneous determination of multiple anticonvulsant drug levels by gas-liquid chromatography. Neurology 1972; 22: 540
   PubMed Web of Science ®Google Scholar
• Evenson M. A., Jones P., Darcey B. Simultaneous measurement of diphenylhydantoin and primidone in serum by gas-liquid chromatography. Clin. Chem. 1970; 16: 107
   PubMed Web of Science ®Google Scholar
• Olesen O. V., Dam M. The metabolic conversion of primidone (Mysoline) to phenobarbital in patients under long-term treatment. Acta Neurol. Scand. 1967; 43: 348
   PubMed Web of Science ®Google Scholar
• Booker H. E., Hozokown K., Burdette R. D., Darcey B. A clinical study of serum primidone levels. Epilepsia 1970; 11: 395
   PubMed Web of Science ®Google Scholar
• Booker H. E. Primidone: Toxicity. Antiepileptic Drugs, D. M. Woodbury, J. Kiffen Penny, R. P. Schmidt. Raven Press, New York 1972; 380
   Google Scholar
• Bush M. T., Helman E. Quantitative determination of primidone. Life Sci. 1965; 4: 1403
   PubMedGoogle Scholar
• Meinardi H. Carbamazepine. Antiepileptic Drugs, D. M. Woodbury, J. Kiffen-Penny, R. P. Schmidt. Raven Press, New York 1972; 487
   Google Scholar
• Meijer J. W. A. Simultaneous quantitative determination of anti-epileptic drugs, including carbamazepine, in body fluids. Epilepsia 1971; 12: 341
   PubMed Web of Science ®Google Scholar
• Kupferberg H. J. Gas-liquid chromatographic determination of carbamazepine in plasma. J. Pharm. Sci. 1972; 61: 284
   PubMed Web of Science ®Google Scholar
• Friel P., Green J. R. Quantitative assay for carbamazepine serum levels by gas-liquid chromatography. Clin. Chim. Acta 1973; 43: 69
   PubMed Web of Science ®Google Scholar
• Roger J. C., Rodgers G., Soo A. Simultaneous determinations of carbamazepine (“Tegretol”) and other anticonvulsants in human plasma by gas-liquid chromatography. Clin. Chem. 1973; 19: 590
   PubMed Web of Science ®Google Scholar